Natalie K. Binder
0000-0002-8943-2269
42 papers found
Refreshing results…
The Regulation of Endothelin-1 in Pregnancies Complicated by Gestational Diabetes: Uncovering the Vascular Effects of Insulin
Assessment of the tocolytic nifedipine in preclinical primary models of preterm birth
Investigating the Effects of Atrial Natriuretic Peptide on the Maternal Endothelium to Determine Potential Implications for Preeclampsia
Sulfasalazine for the treatment of preeclampsia in a nitric oxide synthase antagonist mouse model
Repurposing existing drugs as a therapeutic approach for the prevention of preterm birth
Placental DAAM2 is unaltered in preeclampsia, but upregulated by treatment with proton pump inhibitors
Hydroxychloroquine reduces soluble Flt-1 secretion from human cytotrophoblast, but does not mitigate markers of endothelial dysfunction in vitro
The effect of metformin on cardiovascular markers in female mice consuming a high fat diet
Serum Collected from Preeclamptic Pregnancies Drives Vasoconstriction of Human Omental Arteries—A Novel Ex Vivo Model of Preeclampsia for Therapeutic Development
Placental OLAH Levels Are Altered in Fetal Growth Restriction, Preeclampsia and Models of Placental Dysfunction
Assessment of the Proton Pump Inhibitor, Esomeprazole Magnesium Hydrate and Trihydrate, on Pathophysiological Markers of Preeclampsia in Preclinical Human Models of Disease
The L-NAME mouse model of preeclampsia and impact to long-term maternal cardiovascular health
Actions of Esomeprazole on the Maternal Vasculature in Lean and Obese Pregnant Mice with Impaired Nitric Oxide Synthesis: A Model of Preeclampsia
NR4A2 expression is not altered in placentas from cases of growth restriction or preeclampsia, but is reduced in hypoxic cytotrophoblast
LOX-1 expression is reduced in placenta from pregnancies complicated by preeclampsia and in hypoxic cytotrophoblast
Pre-eclampsia: Challenges for Nanomedicine Development in Pregnancy
Pre-Clinical Investigation of Cardioprotective Beta-Blockers as a Therapeutic Strategy for Preeclampsia
DAAM2 is elevated in the circulation and placenta in pregnancies complicated by fetal growth restriction and is regulated by hypoxia
Nicotinamide and its effects on endothelial dysfunction and secretion of antiangiogenic factors by primary human placental cells and tissues: Treating preeclampsia with nicotinamide
Novel approaches to combat preeclampsia: From new drugs to innovative delivery
Missing publications? Search for publications with a matching author name.